The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...

The first nalmefene hydrochloride (HCl) auto-injector (Zurnai) brings a new tool to the fight against the opioid overdose epidemic but is not without controversy. As reported earlier this month, the ...

Three opioid antagonists, naloxone, naltrexone, and nalmefene, are currently approved for human use. Naloxone and nalmefene have been approved for parenteral administration and are used in the ...

Learn the correct pronunciation of the Nalmefene, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special precautions, warnings ...

Nalmefene has a significant potential for helping individuals with alcohol dependence in reducing their alcohol consumption and allowing individuals to be in control of their alcohol intake The ...

Review the side-effects of Nalmefene as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Credit: Shutterstock. Nalmefene HCl is an alternative to naloxone to reverse the effects of opioids, including respiratory depression, sedation, and hypotension. The Food and Drug Administration (FDA) ...

Purdue Pharma has obtained the Food and Drug Administration’s clearance for nalmefene hydrochloride injection, 2mg/2mL (1mg/1mL). Nalmefene is an opioid antagonist indicated for the complete or ...

The Appraisal Committee considered evidence submitted by the company of nalmefene and a review of this submission by the Evidence Review Group (ERG). The company identified 3 randomised controlled ...

Pharmacodynamic studies have shown that nalmefene has a longer duration of action than naloxone. Nalmefene Hydrochloride Injection is now available for the complete or partial reversal of opioid drug ...